We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 51 start-ups with an aggregate funding of $4.0b. The average funding per company in this subset is $77.7m.
Last update to the database: Feb 18, 2025. See changelog.
Arzeda is a biotechnology and software company designing custom microorganisms for industrial applications through computational enzyme design, protein optimization, and metabolic engineering.
5
Funding Rounds
$72.2m
Money raised
Rigetti Computing is a quantum computing company based in Berkeley, California.
10
Funding Rounds
$269.5m
Money raised
Insilico Medicine is a drug discovery, artificial intelligence company that looks to treat cancer and age related diseases
6
Funding Rounds
$356.3m
Money raised
Molecular Assemblies, Inc. is an enzymatic DNA synthesis technology founded in 2013 by Curt Becker, Bill Efcavitch and William Efcavitch.
7
Funding Rounds
$83.0m
Money raised
Solugen is a speciality chemical manufacturing company developing aiming to replace petroleum-based chemicals with alternatives made from plant-based substitutes.
9
Funding Rounds
$474.1m
Money raised
Metabolon is a company developing metabolomics analytical methods and software for biomarker discovery
5
Funding Rounds
$57.1m
Money raised
Zapata Computing is a company developing quantum software and algorithms for business founded in 2017 by Christopher Savoie, Alán Aspuru-Guzik, Jhonathan Romero Fontalvo, Jonathan Olson, Peter Johnson and Yudong Cao.
6
Funding Rounds
$107.6m
Money raised
DNA synthesis company using enzymatic DNA synthesis based in San Francisco.
4
Funding Rounds
$87.8m
Money raised
Oxford Drug Design Limited is a company that focuses on developing and delivering services and technologies for computer-aided drug discovery
5
Funding Rounds
$10.0m
Money raised
Genapsys is a company developing DNA sequencing technologies and systems founded in 2010 by Hesaam Esfandyarpour.
10
Funding Rounds
$402.1m
Money raised
Nanome is a company developing software for life sciences, materials sciences and nano-engineering with the use of virtual reality and blockchain technology.
4
Funding Rounds
$6.4m
Money raised
TFF Pharmaceuticals is a dry-powder Inhalation for Respiratory Therapies founded in 2018.
2
Funding Rounds
$22.2m
Money raised
Redesign Science Inc is a computational chemistry company that is interested in small molecule drug discovery
2
Funding Rounds
$7.4m
Money raised
Qu & Co is a company that offers quantum-computational chemistry as-a-service.
2
Funding Rounds
Crown bioscience is a company that is focused on research, drug discovery and development for the treatment of cancer and diabetes.
6
Funding Rounds
$62.1m
Money raised
A non-profit organization with a focus on scientific and engineering research. It was founded in 1941 and is located in Birmingham, Alabama.
2
Funding Rounds
$8.7m
Money raised
Pili is a biotechnology company using microorganisms fed sugar to synthesize commercial quality dyes.
9
Funding Rounds
$40.9m
Money raised
Biocrates Life Sciences AG is an Innsbruck-based medical diagnostics company focused on metabolomic research and technology.
8
Funding Rounds
$13.6m
Money raised
AM-Pharma is a biopharmaceutical company developing recombinant human Alkaline Phosphatase (AP) therapeutics, which have the potential to treat patients with Acute Kidney Injury, Inflammatory Bowel Disease and Hypophosphatasia.
3
Funding Rounds
$302.8m
Money raised
ReviveMed is a biotech start-up that analyses metabolomic data using artificial intelligence, which allows them to design new medical therapeutics.
2
Funding Rounds
$1.5m
Money raised
OyaGen is an HIV Drug Discovery, Editing Enzymes founded in 2003 by Harold Smith.
5
Funding Rounds
$6.6m
Money raised
QunaSys is a Bunkyo, Tokyo-based information technology company.
3
Funding Rounds
$2.8m
Money raised
Almac is a biomedical services company based in the UK founded in 1968 by Allen McClay.
2
Funding Rounds
$1.4m
Money raised
A company that provides services and technologies for the development and commercialization of biopharmaceutical products
2
Funding Rounds
$20.0m
Money raised
Small molecule inhibitors of RNA-modifying enzymes for the treatment of cancer
4
Funding Rounds
$101.6m
Money raised
Nimbus Therapeutics is a Computer-Based Drug Discovery founded in 2011 by Bruce Booth.
4
Funding Rounds
$53.0m
Money raised
Sygnature Discovery Limited is a drug Discovery Contract Research founded in 2004 by Simon Hirst.
1
Funding Rounds
Lyndra Therapeutics is a drug Delivery founded in 2015.
3
Funding Rounds
$143.0m
Money raised
Encodia Inc. is a protein Analysis Technologies founded in 2015.
1
Funding Rounds
$75.0m
Money raised
Nitrase Therapeutics is a Brisbane, California-based company offering a biopharmaceutical platform, Nitrome, designed to offer therapies against a broad variety of diseases.
1
Funding Rounds
$83.0m
Money raised
HelixBind is a Marlborough, Massachusetts-based medical diagnostics company developing diagnostic platforms for invasive infections founded in 2012 by Alon Singer.
1
Funding Rounds
$1.7m
Money raised
Cirius Therapeutics is a company developing an insulin sensitizer for the treatment of non-alcoholic steatohepatitis.
1
Funding Rounds
$40.0m
Money raised
Enzymatics is a Beverly, Massachusetts-based biological products customizing company.
1
Funding Rounds
$3.8m
Money raised
Apostle Inc is a Sunnyvale, California-based company providing technologies and services for public health and life sciences.
2
Funding Rounds
$5.7m
Money raised
Element Biosciences is a genetic analysis tools.
2
Funding Rounds
$291.0m
Money raised
Sagimet Biosciences Inc. is a drugs targeting the fatty acid synthase enzyme.
3
Funding Rounds
$185.0m
Money raised
SFA Therapeutics is a microbiome-derived metabolites as drugs founded in 2016 by Ira Spector, Mark Feitelson and Alla Arzumanyan.
1
Funding Rounds
$4.0m
Money raised
BioHybrid Solutions is a company founded by Krzysztof Matyjaszewski, Alan Russell and Antonina Simakova.
1
Funding Rounds
Poxel is a biopharmaceutical company developing drugs for metabolic diseases founded in 2009.
1
Funding Rounds
$20.3m
Money raised
Debut Biotechnology is a Cell-Free Biomanufacturing.
2
Funding Rounds
$25.2m
Money raised
Exo Therapeutics is a small Molecule Drug Discovery.
1
Funding Rounds
$78.0m
Money raised
reMYND is a preclinical In-Vivo Alzheimer's Contract Research.
1
Funding Rounds
$14.5m
Money raised
Molecule.one makes universal working environment software for synthetic planning chemists.
1
Funding Rounds
$4.6m
Money raised
ReadCoor is a Cambridge, Massachusetts-based company founded in 2016 by Evan Daugharthy.
3
Funding Rounds
$80.1m
Money raised
Developer of therapeutics for chronic autoimmune and inflammatory diseases.
2
Funding Rounds
$80.0m
Money raised
Boragen is a United States-based company.
1
Funding Rounds
$10.0m
Money raised
Oxyrane is an enzyme replacement therapies.
1
Funding Rounds
$26.5m
Money raised
EdenRoc Sciences LLC is a Cambridge, Massachusetts-based company founded in 2016.
7
Funding Rounds
$139.0m
Money raised
Xheme Inc. is a company founded in 2019.
2
Funding Rounds
$3.5m
Money raised
Azafaros is a small Molecules.
1
Funding Rounds
$27.5m
Money raised
Adlai Nortye Biopharma is a China-based company.
1
Funding Rounds
$53.0m
Money raised